Replies to post #4037 on Biotech Values

[Biowatch]

>>Moreover, Alpharma's action forced Pfizer to launch its own authorized generic, putting the drug giant in an awkward position in the pending patent litigation: How is Pfizer going to argue to the court that it would be irreparably harmed by a generic if it was putting one out itself?<<

I thought this might be a more telling comment from the article.